利福昔明
医学
肝性脑病
肝硬化
重症监护医学
肝病
全身炎症
苯二氮卓
乳果糖
氟马西尼
抗生素
内科学
胃肠病学
药理学
炎症
生物
微生物学
受体
标识
DOI:10.1517/14656561003724721
摘要
Intestinal ammoniagenesis requires flora modification by antibiotics, prebiotics and probiotics; glutaminase inhibition as well as antibiotics to pre-empt systemic inflammation. Hemodynamic/fluid support is essential. Nutritional support is crucial and hypoproteinemic diets should be avoided. Blocking benzodiazepine-like compounds by the use of flumazenil could be useful in patients with severe, benzodiazepine-induced HE. Long-term rifaximin is well tolerated, does not promote resistance and could decrease overt HE bouts in patients with previous episodes of overt HE. Lactulose is better than no treatment in improving quality of life in patients with minimal HE; it also acts as secondary prophylaxis following overt HE.
科研通智能强力驱动
Strongly Powered by AbleSci AI